4//SEC Filing
GIMV NV 4
Accession 0001209191-04-020327
CIK 0001062216other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:54 PM ET
Size
18.9 KB
Accession
0001209191-04-020327
Insider Transaction Report
Form 4
GIMV NV
Other
Transactions
- Conversion
Common Stock
2004-04-08+166,408→ 166,408 total - Conversion
Series C Convertible Preferred Stock
2004-04-08−200,000→ 0 total→ Common Stock (71,170 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−1,395,349→ 0 total(indirect: See Footnote)→ Common Stock (465,116 underlying) - Conversion
Series B Convertible Preferred Stock
2004-04-08−285,714→ 0 total→ Common Stock (95,238 underlying) - Conversion
Common Stock
2004-04-08+465,116→ 465,116 total(indirect: See Footnote)
Transactions
- Conversion
Series B Convertible Preferred Stock
2004-04-08−285,714→ 0 total→ Common Stock (95,238 underlying) - Conversion
Common Stock
2004-04-08+465,116→ 465,116 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−1,395,349→ 0 total(indirect: See Footnote)→ Common Stock (465,116 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−200,000→ 0 total→ Common Stock (71,170 underlying) - Conversion
Common Stock
2004-04-08+166,408→ 166,408 total
Footnotes (5)
- [F1]The shares of Series D Convertible Preferred Stock reported consist of shares held of record by each of the entities listed below. GIMV and Adviesbeheer GIMV Life Sciences each owned 1,186,047 and 209,302 shares of Series D Convertible Preferred Stock respectively. Upon conversion, GIMV and Adviesbeheer GIMV Life Sciences each own 395,349 and 69,767 shares of common stock respectively. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F2]Each share of Convertible Preferred Stock converted into .3333 shares of Common Stock.
- [F3]These securities automatically converted into Common Stock upon the closing of the Issuer's intitial public offering.
- [F4]These securities do not have an expiration date.
- [F5]Each share of Convertible Preferred Stock converted into .3559 shares of Common Stock.
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeother
Related Parties
1- filerCIK 0001284391
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:54 PM ET
- Size
- 18.9 KB